ArticleClinical and experimental medicine2024

Real-world experience with CDK4/6 inhibitors in hormone receptor-positive metastatic and recurrent breast cancer: findings from an Asian population.

Bo-Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.